v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Preferred stock
Common stock
Surplus
Treasury stock
Retained earnings
Accumulated other comprehensive loss
Beginning balance at Dec. 31, 2024 $ 6,344,297 $ 412,500 $ 66,560 $ 2,482,561 $ (6,153) $ 3,897,164 $ (508,335)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 384,566         384,566  
Other comprehensive income (loss), net of tax 142,102           142,102
Cash dividends declared on common stock (66,825)         (66,825)  
Dividends on Series D E and F preferred stock (13,982)         (13,982)  
Stock-based compensation 20,575     20,575      
Issuance of Series F Preferred Stock 414,212 425,000   (10,788)      
Common stock issued for:              
Exercise of stock options 220   5 215      
Restricted stock awards (3,003)   425 (425) (3,003)    
Employee stock purchase plan 1,765   16 1,749      
Director compensation plan 1,769   19 1,750      
Ending balance at Jun. 30, 2025 7,225,696 837,500 67,025 2,495,637 (9,156) 4,200,923 (366,233)
Beginning balance at Mar. 31, 2025 6,600,537 412,500 67,007 2,494,347 (9,156) 4,045,854 (410,015)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 195,527         195,527  
Other comprehensive income (loss), net of tax 43,782           43,782
Cash dividends declared on common stock (33,467)         (33,467)  
Dividends on Series D E and F preferred stock (6,991)         (6,991)  
Stock-based compensation 10,164     10,164      
Issuance of Series F Preferred Stock 414,212 425,000   (10,788)      
Common stock issued for:              
Exercise of stock options 1     1      
Restricted stock awards 0   8 (8)      
Employee stock purchase plan 990   9 981      
Director compensation plan 941   1 940      
Ending balance at Jun. 30, 2025 7,225,696 837,500 67,025 2,495,637 (9,156) 4,200,923 (366,233)
Beginning balance at Dec. 31, 2025 7,258,715 425,000 67,062 2,534,024 (9,156) 4,537,539 (295,754)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 461,081         461,081  
Other comprehensive income (loss), net of tax (125,044)           (125,044)
Cash dividends declared on common stock (74,098)         (74,098)  
Dividends on Series D E and F preferred stock (16,734)         (16,734)  
Stock-based compensation 22,988     22,988      
Common stock issued for:              
Exercise of stock options 95   2 93      
Restricted stock awards (5,726)   474 (474) (5,726)    
Employee stock purchase plan 1,823   13 1,810      
Director compensation plan 2,016   30 1,986      
Ending balance at Jun. 30, 2026 7,525,116 425,000 67,581 2,560,427 (14,882) 4,907,788 (420,798)
Beginning balance at Mar. 31, 2026 7,378,100 425,000 67,563 2,546,754 (13,970) 4,719,561 (366,808)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 233,693         233,693  
Other comprehensive income (loss), net of tax (53,990)           (53,990)
Cash dividends declared on common stock (37,099)         (37,099)  
Dividends on Series D E and F preferred stock (8,367)         (8,367)  
Stock-based compensation 11,664     11,664      
Common stock issued for:              
Restricted stock awards (912)   10 (10) (912)    
Employee stock purchase plan 1,021   7 1,014      
Director compensation plan 1,006   1 1,005      
Ending balance at Jun. 30, 2026 $ 7,525,116 $ 425,000 $ 67,581 $ 2,560,427 $ (14,882) $ 4,907,788 $ (420,798)